Answers are grounded in this paper and cite their sources.
Brief Reports15 May 1991Accuracy of Fecal Occult Blood Test InterpretationMartin Fleisher, PhD, Sidney J. Winawer, MD, Ann Graham Zauber, PhD, Carol Smith, BS, Morton K. Schwartz, PhDMartin Fleisher, PhD, Sidney J. Winawer, MD, Ann Graham Zauber, PhD, Carol Smith, BS, Morton K. Schwartz, PhDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-114-10-875 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe fecal occult blood test is widely used in clinical practice, and its results often help physicians decide whether to pursue the diagnostic work-up of patients (1-3). Although considerable emphasis has been placed on dietary interferences, laboratory and clinical sensitivity, and the predictive value of the test, little attention has been focused on test interpretation (4). Because the fecal occult blood test is being used in the National Polyp Study follow-up (5), a proficiency test program was established to monitor the accuracy of interpretation. The program coordinators' proficiency was evaluated before and after a 1-hour instructional seminar on the correct...References1. ShikeWinawer MS. Primary and secondary prevention of colorectal cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer Prevention. Philadelphia: J. B. Lippincott Co.; 1990:1-10. Google Scholar2. AllisonFeldmanTekawa JRI. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting. Ann Intern Med. 1990;112:328-33. LinkGoogle Scholar3. Greegor D. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA. 1987;201:943-5. CrossrefGoogle Scholar4. FleisherSchwartzWinawer MMS. Fecal occult blood testing. In: Miller AB, ed. Screening for Cancer. Orlando, Florida: Academic Press; 1985:237-47. Google Scholar5. WinawerZauberO'Brien SAM. The National Polyp Study: overview of program and preliminary report of patient and polyp characteristics. Basic and clinical perspectives of colorectal polyps and cancer. In: Steele G Jr, Burt RW, Winawer SJ, Karr JP, eds. Progress in Clinical and Biological Research. New York: Alan R. Liss; 1988:35-49. Google Scholar6. Winer B. Statistical Principles in Experimental Design. New York: McGraw-Hill; 1971. Google Scholar7. BMDP Statistical Software. Berkeley, California: University of California Press; 1988. Google Scholar8. GnauckMacraeFleisher RFM. How to perform the fecal occult blood test. CA. 1984;34:134-47. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: National Polyp Study Work Group *From Memorial Sloan-Kettering Cancer Center, New York, New York.For current author addresses, see end of text.*For members of the National Polyp Study Work Group, see reference #5. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAdvances in Fecal Occult Blood Tests: The FIT RevolutionThe History of Colorectal Cancer Screening: A Personal PerspectiveQuality Indicators and Benchmarks for Guideline-Recommended Fecal Occult Blood TestsTests and investigations for colorectal cancer screeningPopulation Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)FIT Testing: An OverviewPerformance improvements of stool-based screening testsNew Screening Guidelines for Colorectal Cancer: A Practical Guide for the Primary Care PhysicianComparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma DetectionSabrina Hundt, MSc, Ulrike Haug, PhD, and Hermann Brenner, MD, MPHCancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendationsImplications of New Colorectal Cancer Screening Technologies for Primary Care PracticeSCREENING FOR COLORECTAL CANCERColon Cancer Screening Guidelines 2005: The Fecal Occult Blood Test Option Has Become a Better FITFrom Guaiac to Immune Fecal Occult Blood TestsThe replyScreening for colorectal cancer 2003: is there still a role for the FOBT?Point-of-Care TestingPromoting early detection tests for colorectal carcinoma and adenomatous polypsMeasuring interval cancers in population-based screening using different assays of fecal occult blood testing: The district of Florence experienceEffect of Dietary Factors on the Detection of Fecal Occult Blood in CatsFaecal occult blood test screening for colorectal cancer - what are we waiting for?Screening for colorectal cancer: present, past and futureShould All People over the Age of 50 Have Regular Fecal Occult-Blood Tests?A study of laboratory based faecal occult blood testing in Melbourne, AustraliaReview article: faecal occult blood testing for colorectal cancerScreening for Colorectal Cancer by Immunochemical Fecal Occult Blood TestingDiagnostic value of a guaiac occult blood test and faecal alpha 1-antitrypsin.Detection of Colorectal Cancer by Faecal α 1 -AntitrypsinThe national polyp study design, methods, and characteristics of patients with newly diagnosed polypsGastrointestinal Disorders in the AthleteStandardizing Fecal Occult Blood TestingSiva Maran, MD, Thomas P. Short, MD, Eapen Thomas, MD 15 May 1991Volume 114, Issue 10Page: 875-876KeywordsClinical laboratoriesHematologic testsResearch laboratories ePublished: 1 December 2008 Issue Published: 15 May 1991 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Fleisher et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: